GitLab Inc. ( NASDAQ: GTLB) Piper Sandler Growth Frontiers Conference September 11, 2025 11:00 AM EDT ...

Manchester United’s recent Carabao Cup match against Grimsby Town was nothing short of a nightmare. The match ended in a 2-2 draw, and the League Two side won 12-11 in a penalty shootout. Charles ...

Key Capital Partners has announced a director appointment (image credit: Pixabay) Private equity firm Key Capital Partners has appointed a new director to deepen connections across the North West and ...

The DVLA has launched a big driving law change - and promised to slash red tape for the classic car industry. The DVLA, which now operates under a Labour Party government, is looking to make it easier ...

A major exhibition bout heads to Atlanta as Paul meets Davis in a fight fans won’t want to miss The business of boxing never sleeps, and few names keep the wheels turning like Jake Paul. Fresh off ...

GREEN BAY (WLUK) -- An online public meeting is set to learn more on safety improvements coming to seven Green Bay area intersections. The meeting is set for Monday, Aug. 25 at 5 p.m. For full audio ...

Nicholas Hoult as Lex Luthor, David Corenswet as Superman and Director Janes Gunn on the set of " Superman" (Credit: Jessica Miglio/ © Warner Bros. Entertainment ...

Call of Duty: Black Ops 7 looks set to skip the Nintendo Switch 2 at launch, despite parent company Microsoft’s “binding 10-year legal agreement” to bring Call of Duty to Nintendo platforms. In 2023, ...

Keysight Technologies, Inc. KEYS is scheduled to report third-quarter fiscal 2025 results on Aug. 19, after the closing bell. It pulled off a trailing four-quarter earnings surprise of 8.19%, on ...

Many high-end games, professional software, and cloud security applications now require Secure Boot and TPM 2.0 features, which are only supported when the system disk uses the GPT partition format.

Genmab and AbbVie are taking key steps toward moving their blood cancer drug Epkinly into earlier lines of treatment in follicular lymphoma (FL). On Thursday, Genmab reported results from a phase 3 ...